Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis

OBJECTIVES: Immune checkpoint inhibitors (ICIs) have brought impressive benefits to cancer patients, however often accompanied with immune-related adverse events (irAEs). We aimed to investigate the association of irAEs with efficacy and overall survival in cancer patients treated by ICIs, and furth...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yong, Xie, Wenhui, Huang, Hong, Wang, Yunxia, Li, Guangtao, Geng, Yan, Hao, Yanjie, Zhang, Zhuoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072154/
https://www.ncbi.nlm.nih.gov/pubmed/33912454
http://dx.doi.org/10.3389/fonc.2021.633032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072154/
https://www.ncbi.nlm.nih.gov/pubmed/33912454
http://dx.doi.org/10.3389/fonc.2021.633032

Ejemplares similares